Skip to main content

Table 1 Clinical characteristics of participants at baseline

From: The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes

Baseline characteristic Diacerein group
(n = 18)
Placebo group
(n = 17)
P-value
Age (year) 54.7 ± 1.2 52 ± 3.1.7 0.23
Female sex, n (%) 13 (72.2) 9 (52.9) 0.51
Duration of diabetes (year) 12.5 ± 1.5 11.4 ± 1.1 0.55
Body mass index (kg/m2) 29.3 ± 1.0 29.5 ± 1.2 0.86
Fasting plasma glucose (mg/dL) 162.9 ± 8.7 165.9 ± 10.7 0.71
HbA1c (%) 8.4 ± 0.1 8.5 ± 0.2 0.83
hsCRP (mg/dL)* 0.86 (0.62–2.31) 1.42 (1.11–2.22) 0.12
  1. Values are shown as mean ± SE
  2. HbA1c glycated haemoglobin, hsCRP High Sensitivity C-Reactive Protein
  3. *Median (interquartile range)